Selective nicotinic receptor consequences in APPSWE transgenic mice

Molecular and Cellular Neuroscience

Volumn 20, Issue 2, 2002, Pages 354-365

  Bednar, Ivan ^a   Paterson, David ^a   Marutle, Amelia ^a   Pham, Therese M ^a   Svedberg, Marie ^a   Hellström Lindahl, Ewa ^a   Mousavi, Malahat ^a   Court, Jennifer ^b   Morris, Christopher ^b   Perry, Elaine ^b   Mohammed, Abdul ^a   Zhang, Xiao ^a   Nordberg, Agneta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BUNGAROTOXIN RECEPTOR; CYTISINE; IODINE 125; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; NICOTINIC RECEPTOR; PIRENZEPINE; TRITIUM;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN DISEASE; BRAIN REGION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; FEMALE; LEARNING DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0036318339     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2002.1112     Document Type: Article

References (56)

1. Beta-amyloid peptides as direct cholinergic neuromodulators: A missing link?
2. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein London mutant transgenic mice
3. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
4. Nicotinic receptor abnormalities in Alzheimer's disease
5. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease
6. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein
7. SW trasngenic mice
8. Alpha-bungarotoxin binding to hippocampal interneurons: Immunocytochemical characterization and effects on growth factor expression
9. In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice
10. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease
11. Suppressed expression of nicotinic acetylcholine receptors by nanomolar β-amyloid peptides in PC12 cells
12. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between alzheimer and normal brain
13. Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging
14. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes
15. Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis: Possible role in cholinergic dysfunction in Alzheimer's disease
16. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
17. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins
18. Correlative memory deficits, Abeta elevation and amyloid plaques in transgenic mice
19. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1
20. Abundance of the longer A beta 42 in neocortical and cerebrovascular amyloid beta deposits in Swedish familial Alzheimer's disease and Down's syndrome
21. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices
22. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices
23. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons
24. The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: Studies with DMXBA (GTS-21)
25. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease
26. The elimination of enzymatic diffusion artefacts in the histochemical localisation of cholinesterase and a survey of their cellular distribution
27. Beta-amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons
28. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation
29. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
30. Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs
31. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
32. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice
33. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
34. Human nicotinic receptors - Their role in aging and dementia
35. Nicotinic receptor abnormalities of Alzheimer's disease: Therapeutic implications
36. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains
37. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: A chronic oxidative paradigm for testing antioxidant therapies in vivo
38. Effects of environmental enrichment on cognitive function and hippocampal NGF in the non-handled rats
39. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice
40. Adaptation of the circular platform spatial memory task for mice: Use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease
41. NIH image: A public domain image processing program for the Macintosh
42. Nicotinic receptors in the development and modulation of CNS synapses
43. Acetylcholines-terase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease
44. Transgenic animals relevant to Alzheimer's disease
45. Nicotinic receptor-mediated protection against β-amyloid neurotoxicity
46. 3H]epibatidine in vitro autoradiography
47. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress
48. Molecular genetics of Alzheimer's disease
49. Researchers find evidence of a new gene for late-onset Alzheimer disease
50. Single and multiple transgenic mice as models for Alzheimer's disease
51. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation
52. Beta-amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity: Implications for Alzheimer's disease pathology
53. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains
54. Presynaptic nicotinic receptors and the modulation of transmitter release
55. Postnatal changes of nicotinic acetylcholine receptor alpha 2, alpha 3, alpha 4, alpha 7 and beta 2 subunits genes expression in rat brain
56. 125]alpha-bungarotoxin binding sites in brain than rats not exhibiting tolerance